English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Sanofi Us
Press release submission
| May 8, 2018
SANOFI US: Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients
Carol Ostrow
| Oct 7, 2017
Dupixent gains approval as atopic dermatitis treatment in Europe
Nicholas Gueguen
| Jul 23, 2017
Study: Dupixent used with topical corticosteroids improves atopic dermatitis
Nicholas Gueguen
| Jul 1, 2017
FDA OKs Kevzara for moderate to severe rheumatoid arthritis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Robert Hadley
| Apr 15, 2017
Toujeo maker touts drug’s ability to lower blood sugar
Erianne Leatherman
| Apr 5, 2017
Sanofi Genzyme expands Multiple Myeloma Journey Partners program
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
Patient Daily
| Aug 1, 2025
Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’
Patient Daily
| Aug 4, 2025
Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
+
Pharmaceuticals
Patient Daily
| Aug 5, 2025
American Lung Association study urges schools to prioritize clean classroom air
Patient Daily
| Aug 7, 2025
Dallas Breathe Free Sinus & Allergy Centers earns 4.8-star rating from 670 Google reviews
